Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
proteus infections
MeSH D011512 - proteus infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004756:
Enterobacteriaceae infections
38 Companies
7 Drugs
$
Success rate
D011512:
Proteus infections
146 Companies
59 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
48/48
Approved:
48
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Avibactam
,
Ceftazidime
Allergan
Ciprofloxacin
,
Gatifloxacin
,
Levofloxacin
,
Ofloxacin
,
Prednisolone
,
Prednisolone tebutate
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use